相关实验视频
Updated: May 27, 2025

04:08
Metacarpal Small Incision for Carpal Tunnel Syndrome
Published on: April 5, 2024
372
抗血小板和抗凝剂在超声波导向无切割线程手腕道释放期间的使用
Kaylie P Dean1, Brandon J Smith1, Alexander Y Shin1
1Mayo Clinic, Rochester, MN, USA.
概括
在无切口线手腕道释放 (TCTR) 期间继续抗血小板治疗似乎是安全的. 这项研究发现,当患者在手术期间保持抗凝血或抗血小板药物时,没有显著的出血风险.
科学领域:
- 整形外科 整形外科 整形外科
- 神经外科 神经外科
- 血管外科 血管外科
背景情况:
- 带道综合征 (CTS) 是最常见的外周神经陷.
- 线程手足道释放 (TCTR) 提供了一种无切口,超声波引导的方法,用于横向手足带分裂.
研究的目的:
- 评估在TCTR期间持续抗凝血或抗血小板治疗相关的出血风险.
- 评估TCTR在服用抗血栓药物的患者中的安全性.
主要方法:
- 114名成年患者进行了164次TCTR手术 (2018-2023年) 的回顾性病例系列.
- 患者正在服用抗血小板或抗凝血药物.
- 图表审查和后续问卷调查确定了TCTR期间与药物管理相关的不良事件.
主要成果:
- 没有观察到任何重大并发症.
- 在TCTR期间不继续或不持续抗凝或抗血小板治疗导致不良出血事件.
结论:
- 在TCTR期间继续抗血小板治疗被认为是安全的.
- 在TCTR期间管理抗凝血或抗血小板治疗时,个性化患者评估至关重要.
相关概念视频
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
457
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
457
Anticoagulant Drugs: Low-Molecular-Weight Heparins
597
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
597

